Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Memorial Sloan-Kettering Cancer Center National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00059943 |
RATIONALE: Drugs used in chemotherapy, such as docetaxel, use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well docetaxel works in treating older patients with metastatic breast, lung, or prostate cancer.
Condition | Intervention | Phase |
---|---|---|
Breast Cancer Lung Cancer Prostate Cancer |
Drug: docetaxel |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Open Label |
Official Title: | Pharmacokinetics of Weekly Docetaxel in Patients Age 65 and Older With Metastatic Breast or Lung Cancer |
Study Start Date: | September 2002 |
OBJECTIVES:
OUTLINE: Patients receive docetaxel IV over 30 minutes once weekly for 3 weeks. Courses repeat every 4 weeks in the absence of disease progression or unacceptable toxicity.
PROJECTED ACCRUAL: A total of 20 patients will be accrued for this study within 1 year.
Ages Eligible for Study: | 65 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Hormone receptor status:
PATIENT CHARACTERISTICS:
Age
Sex
Menopausal status
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
Cardiovascular
Other
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Other
United States, New York | |
Memorial Sloan-Kettering Cancer Center | |
New York, New York, United States, 10021 |
Study Chair: | Arti Hurria, MD | Memorial Sloan-Kettering Cancer Center |
Study ID Numbers: | CDR0000298989, MSKCC-01136 |
Study First Received: | May 6, 2003 |
Last Updated: | July 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00059943 |
Health Authority: | United States: Federal Government |
stage IV breast cancer stage IV non-small cell lung cancer recurrent non-small cell lung cancer |
recurrent breast cancer stage IV prostate cancer recurrent prostate cancer |
Thoracic Neoplasms Non-small cell lung cancer Prostatic Diseases Skin Diseases Genital Neoplasms, Male Breast Neoplasms Urogenital Neoplasms Genital Diseases, Male |
Recurrence Docetaxel Respiratory Tract Diseases Lung Neoplasms Lung Diseases Prostatic Neoplasms Carcinoma, Non-Small-Cell Lung Breast Diseases |
Respiratory Tract Neoplasms Neoplasms Neoplasms by Site |
Antineoplastic Agents Therapeutic Uses Pharmacologic Actions |